Drreddys Laboratories | RDY - Stock


Drreddys Laboratories reported INR76.53B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Bayer EUR 11.97B 43M Jun/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Cipla INR 65.97B 4.37B Mar/2026
Corcept Therapeutics USD 13.18M 295K Jun/2026
Drreddys Laboratories INR 76.53B 2.48B Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Lonza CHF 1.68B 163M Dec/2025
Novartis USD 6.22B 66M Jun/2026
Pacira USD 134.57M 15.8M Jun/2026
Phibro Animal Health USD 534.88M 4.82M Jun/2026
Prestige Brands USD 190.22M 31.08M Jun/2026
Richter Gedeon HUF 205.75B 9.76B Jun/2024
Sun Pharmaceuticals INR 114.93B 12.5B Mar/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026